Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat

A synaptic model of memory: long-term potentiation in the hippocampus

1993 • 11,303 citations

Modification of seizure activity by electrical stimulation: II. Motor seizure

1972 • 6,939 citations

Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis

1991 • 636 citations

The role of glutamate in epilepsy and other CNS disorders.

1994 • 476 citations

Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy

1989 • 179 citations

Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy

1998 • 176 citations

Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models

1993 • 140 citations

Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy

1994 • 104 citations

The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist d-CPPene on the development of amygdala kindling and on amygdala-kindled seizures

1994 • 103 citations

YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.

1996 • 80 citations

Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats

1998 • 66 citations

Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP

1991 • 58 citations

Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).

1995 • 48 citations

Neuroprotective Effect of YM90K, a Novel AMPA/Kainate Receptor Antagonist, in Focal Cerebral Ischemia in Cats

1996 • 48 citations

A crucial role of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures.

1997 • 43 citations

NMDA but Not AMPA Receptor Antagonists Impair the Delay-Interposed Radial Maze Performance of Rats

1997 • 43 citations

Neuroprotective Effect of YM9OK, an AMPA-Receptor Antagonist,against Delayed Neuronal Death Induced by Transient Global Cerebral Ischemia in Gerbils and Rats.

1997 • 33 citations

AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats

1997 • 25 citations

BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy

1997 • 23 citations

NMDA-but not AMPA-receptor antagonists augment scopolamine-induced spatial cognitive deficit of rats in a radial maze task

1996 • 21 citations

Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia

1997 • 21 citations

Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats

1993 • 20 citations

Acute effects of various GABA receptor agonists and glutamate antagonists on focal hippocampal seizures in freely moving rats elicited by low-frequency stimulation

1998 • 18 citations

Pharmacokinetics and Safety of the Novel Amino-3-Hydroxy-5-Methylisoxazole-4-Propionate Receptor Antagonist YM90K in Healthy Men

1997 • 18 citations

MK-801 and NBQX prevent electrically induced status epilepticus

1994 • 16 citations

YM90K, an AMPA Antagonist, Has No Neurotoxic Effects on Cerebrocortical Neurons in Rats

1995 • 12 citations

NMDA- but not AMPA-receptor antagonists augment scopolamine-induced spatial cognitive deficit of rats in a radial maze task

1996 • 8 citations

NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo

1995 • 8 citations

Contributions of Kindling to Clinical Epileptology

1998 • 5 citations

A new nonNMDA antagonist modifies the local cerebral glucose utilization in kainate-induced·, generalized seizure

1997 • 4 citations

A New Non-NMDA Antagonist Modifies the Local Cerebral Glucose Utilization in Kainate-induced Generalized Seizure

1997 • 3 citations